Michael Harris is a seasoned professional in the pharmaceutical industry with extensive experience at Pfizer since September 2015, currently serving as Senior Director and leading the US Migraine Team. Michael has held several key leadership positions, including Global Commercial Lead for Lung Oncology and Director for the Growth Hormone Franchise, where Michael managed product strategies and P&L. Earlier roles at Pfizer involved leading colorectal cancer screening initiatives and developing smoking cessation strategies. Prior to Pfizer, Michael worked at Ernst & Young as a Senior Associate, providing strategy and M&A consulting, and at Bates White Economic Consulting, delivering economic analyses for litigation purposes. Michael holds an MBA from Northwestern University's Kellogg School of Management and a Bachelor of Science in Economics and English from Duke University.
This person is not in any teams
This person is not in any offices